The company, based on science from the Hackensack Meridian Center for Discovery and Innovation, promises to capture biomarkers for early detection of disease
EValuate Diagnostics, the first spin-out company from the Hackensack Meridian Health Research Institute and its Office of Innovation and Commercialization, is the newest addition to Foundation Venture Capital Group’s (FVCG’s) portfolio.